[go: up one dir, main page]

NO984189L - Procedure for the treatment of bipolar disorder - Google Patents

Procedure for the treatment of bipolar disorder

Info

Publication number
NO984189L
NO984189L NO984189A NO984189A NO984189L NO 984189 L NO984189 L NO 984189L NO 984189 A NO984189 A NO 984189A NO 984189 A NO984189 A NO 984189A NO 984189 L NO984189 L NO 984189L
Authority
NO
Norway
Prior art keywords
bipolar disorder
procedure
treatment
provides
present
Prior art date
Application number
NO984189A
Other languages
Norwegian (no)
Other versions
NO984189D0 (en
Inventor
Jr Charles M Beasley
Gary D Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984189D0 publication Critical patent/NO984189D0/en
Publication of NO984189L publication Critical patent/NO984189L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)

Abstract

Foreliggende oppfinnelse fremskaffer en fremgangsmåte for behandling av bipolar for- styrrelse, omfattende administrering av en effektiv mengde olanzapin til en pasient som trenger dette. I tillegg fremskaffer foreliggende oppfinnelse en fremgangsmåte for be- handling av bipolar forstyrrelse, stor depressiv episode.The present invention provides a method for treating bipolar disorder, comprising administering an effective amount of olanzapine to a patient in need thereof. In addition, the present invention provides a method of treating bipolar disorder, major depressive episode.

NO984189A 1996-03-11 1998-09-11 Procedure for the treatment of bipolar disorder NO984189L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11
PCT/US1996/019575 WO1997033577A1 (en) 1996-03-11 1996-12-04 Method for treating bipolar disorder

Publications (2)

Publication Number Publication Date
NO984189D0 NO984189D0 (en) 1998-09-11
NO984189L true NO984189L (en) 1998-09-11

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984189A NO984189L (en) 1996-03-11 1998-09-11 Procedure for the treatment of bipolar disorder

Country Status (15)

Country Link
EP (1) EP0889725A4 (en)
JP (1) JP2000506859A (en)
KR (1) KR19990087713A (en)
CN (1) CN1213966A (en)
AU (1) AU734011B2 (en)
BR (1) BR9612548A (en)
CZ (1) CZ290298A3 (en)
EA (1) EA000758B1 (en)
HU (1) HUP9903679A3 (en)
IL (1) IL126162A0 (en)
NO (1) NO984189L (en)
NZ (1) NZ326031A (en)
PL (1) PL328925A1 (en)
TR (1) TR199801797T2 (en)
WO (1) WO1997033577A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
WO1999061027A1 (en) * 1998-05-22 1999-12-02 Eli Lilly And Company Combination therapy for treatment of refractory depression
AU756468B2 (en) * 1998-05-29 2003-01-16 Eli Lilly And Company Combination therapy for treatment of bipolar disorders
EP1133299A1 (en) 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
EP1135136B1 (en) * 1998-11-23 2003-11-05 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
WO2000030650A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
AU1330797A (en) 1997-10-01
NO984189D0 (en) 1998-09-11
KR19990087713A (en) 1999-12-27
EP0889725A1 (en) 1999-01-13
EA000758B1 (en) 2000-04-24
WO1997033577A1 (en) 1997-09-18
JP2000506859A (en) 2000-06-06
TR199801797T2 (en) 1998-12-21
AU734011B2 (en) 2001-05-31
HUP9903679A2 (en) 2000-04-28
HUP9903679A3 (en) 2001-10-29
CZ290298A3 (en) 1999-10-13
CN1213966A (en) 1999-04-14
PL328925A1 (en) 1999-03-01
IL126162A0 (en) 1999-05-09
NZ326031A (en) 2001-05-25
EP0889725A4 (en) 2000-01-19
EA199800819A1 (en) 1999-02-25
BR9612548A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
ATE279181T1 (en) USE OF 5HT-6 ANTAGONISTS TO TREAT ADHD
DK0723444T3 (en) Levobupivacaine suitable for the treatment of chronic pain
DE60142839D1 (en) Botulinum toxin for the treatment of acute skeletal muscle damage
TR200000755T2 (en) Treatment of anti-oppositional disorder.
DE69814394D1 (en) USE OF LEVOBUPIVACAIN
IS5591A (en) Base protein composition for wound healing
DE69116380D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING EXTENDED COAGLING TIME
ATE214272T1 (en) TOPICAL USE OF KAPPA OPIOID RECEPTOR AGONISTS TO TREAT EYE PAIN
EA199800864A1 (en) METHOD OF TREATMENT FOR PATIENTS CAUSED BY MIGRAINE
NO984189L (en) Procedure for the treatment of bipolar disorder
DE69813200D1 (en) IMPROVING Wounds Healing With CM101 / GBS-TOXIN
NO984446L (en) Procedure for treating pain
DK1237562T3 (en) Process for the preparation of micania extracts containing micanolide and dihydromycanolide and use in the treatment of proliferative diseases
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
EA199800535A1 (en) METHOD OF TREATMENT OF PAIN
ATE306278T1 (en) TREATING BONE DISEASES WITH ADRENOMEDULLIN
ID27052A (en) ARTHRITIS TREATMENT AND OTHER CONDITIONS
NO984196D0 (en) Procedure for the treatment of substance abuse
NO984190L (en) Procedure for the treatment of insomnia
NO990436L (en) Procedure for the treatment of bipolar disorder
NO984198L (en) Procedure for the treatment of aggression
ATE72115T1 (en) APPLICATION OF 1,6-DIMETHYL-4-OXO-1,6,7,8,9A-
NO20024545L (en) Procedures for treating congestive heart failure
NO985325L (en) Use of substituted azaspiran in the treatment of asthma
EA199800820A1 (en) METHOD OF TREATING ABUSE OF MEDICINES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application